Research Grants 3,998 show all


$30.8M
2016

$24.2M
2017

$39.8M
2018

$47.2M
2019

$16.3M
2020

Patents 41show all

  • 17
    A61K - Preparations for medical, dental, or toilet purposes
  • 12
    C07K - Peptides
  • 7
    C07D - Heterocyclic compounds
  • 5
    C07H - Sugars
  • 4
    C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms
  • 4
    G01N - Investigating or analysing materials by determining their chemical or physical properties
  • 3
    A61N - Electrotherapy
  • 3
    C12N - Microorganisms or enzymes
  • 2
    A61B - Diagnosis
  • 1
    A21D - Treatment, e.g. preservation, of flour or dough, e.g. by addition of materials

Web Documents 35show all

Roswell Park Cancer Institute has 35 documents.

Publications 9,566 show all

  • 235
    Antineoplastic Combined Chemotherapy Protocols/therapeutic use
  • 188
    Antineoplastic Agents/therapeutic use
  • 126
    Antineoplastic Agents/pharmacology
  • 120
    Breast Neoplasms/genetics
  • 116
    Neoplasms/drug therapy
  • 92
    Ovarian Neoplasms/genetics
  • 85
    Ovarian Neoplasms/drug therapy
  • 78
    Gene Expression Regulation, Neoplastic
  • 77
    Neoplasms/therapy
  • 76
    Breast Neoplasms/pathology

Clinical Trials 379show all

133Phase 289Phase 182N/A39Phase 1/Phase 225Other